Loading clinical trials...
Loading clinical trials...
Managed Access to Investigational Use of AOC 1044 in Participants With DMD Mutations Amenable to Exon 44 Skipping
Conditions
Interventions
delpacibart zotadirsen
Locations
4
United States
Arkansas Children's Hospital
Little Rock, Arkansas, United States
Rare Disease Research
Atlanta, Georgia, United States
Gillette Children's
Saint Paul, Minnesota, United States
University of Vermont Medical Center
Burlington, Vermont, United States
Last Updated
April 8, 2026
NCT06672237
NCT06243848
NCT05742776
NCT06773169
NCT05842915
NCT06084026
Lead Sponsor
Avidity Biosciences, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions